Business Context and Reporting Period
This Form 6-K filing by Sanofi-Synthelabo (Sanofi) is dated June 1, 2004. The report serves as a notification regarding the expiration date of Sanofi's revised public offer to acquire the ordinary shares of Aventis.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory announcement concerning a corporate transaction rather than a financial performance report.
Material Changes
The primary material event is the confirmation by the French stock market regulator (AMF) that the expiration date for Sanofi's revised offer for Aventis is set for June 30, 2004. This applies to the French, German, and U.S. offers, which are intended to expire simultaneously.
Guidance, Outlook, and Risks
- Offer Expiration: The French and German offers expire at 23:00 Central European Summer Time, and the U.S. offer expires at 5:00 p.m. Eastern Daylight Time on Wednesday, June 30, 2004.
- Tendering Rights: Holders of Aventis securities may tender or withdraw their tendered securities at any time until the expiration of the offers.
- Regulatory Compliance: The offer is subject to conditions outlined in the registration statement on Form F-4 and applicable laws in France, Germany, and the U.S.
- Investor Action: Investors are urged to read the registration statement, prospectus, and prospectus supplement for important information regarding the acquisition.
Key Facts for Investor Verification
- Verify the final expiration date of the acquisition offer: June 30, 2004.
- Confirm the specific tendering deadlines for different jurisdictions (France, Germany, U.S.).
- Review the Form F-4 registration statement (File No. 333-112314) and related prospectuses for detailed terms and conditions of the offer.
- Check the status of regulatory approvals and conditions precedent to the completion of the acquisition.